Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-(3-(6-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-(trifluoromethyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-7-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1034152-93-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-(3-(6-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-(trifluoromethyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-7-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol

    Cas No: 1034152-93-6

  • Need to discuss

  • No requirement

  • Adequate

  • Kono Chem Co.,Ltd
  • Contact Supplier
  • 2-(3-(6-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-(trifluoromethyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-7-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol

    Cas No: 1034152-93-6

  • Need to discuss

  • No requirement

  • Adequate

  • Shangdong Shinning Pharm co.ltd
  • Contact Supplier
  • 1034152-93-6 Structure
  • Basic information

    1. Product Name: 2-(3-(6-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-(trifluoromethyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-7-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol
    2. Synonyms: MK-7725;2-(3-(6-((4-(trifluoroMethoxy)phenyl)sulfonyl)-2-(trifluoroMethyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-7-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol
    3. CAS NO:1034152-93-6
    4. Molecular Formula: C25H19F6N5O5S
    5. Molecular Weight: 615.513
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1034152-93-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-(3-(6-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-(trifluoromethyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-7-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-(3-(6-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-(trifluoromethyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-7-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol(1034152-93-6)
    11. EPA Substance Registry System: 2-(3-(6-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-(trifluoromethyl)-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepin-7-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol(1034152-93-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1034152-93-6(Hazardous Substances Data)

1034152-93-6 Usage

Molecular structure

The compound has a complex structure consisting of a central core with a benzopyrido-diazepin structure, attached functional groups, and a propan-2-ol moiety.

Functional groups

The compound contains several functional groups, including a trifluoromethyl group, a sulfonyl group, an oxadiazol group, and a trifluoromethoxyphenyl group.

Trifluoromethyl group

This group (CF3) is attached to the benzopyrido-diazepin core and is known for its high electronegativity and stability.

Sulfonyl group

The sulfonyl group (SO2) is connected to the phenyl ring and is known for its ability to act as a good leaving group in reactions and can influence the compound's reactivity.

Oxadiazol group

The 1,2,4-oxadiazol group is present in the molecule and is known for its potential pharmacological properties, such as acting as a receptor antagonist.

Trifluoromethoxyphenyl group

This group (OC(CF3)3) is attached to the phenyl ring and can influence the compound's solubility, stability, and pharmacokinetic properties.

Propan-2-ol moiety

The compound also features a propan-2-ol group (CH3CH(OH)CH3), which can participate in hydrogen bonding and solvation, potentially affecting the compound's solubility and pharmacokinetic properties.

Pharmacological properties

The compound is likely to have specific pharmacological properties due to its complex structure and the presence of various functional groups, making it a potential candidate for pharmaceutical research and drug development.

Application in drug development

The compound's unique structure and functional groups may contribute to its potential use in the development of new drugs for various therapeutic applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1034152-93-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,4,1,5 and 2 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1034152-93:
(9*1)+(8*0)+(7*3)+(6*4)+(5*1)+(4*5)+(3*2)+(2*9)+(1*3)=106
106 % 10 = 6
So 1034152-93-6 is a valid CAS Registry Number.

1034152-93-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-{3-[6-{[4-(trifluoromethoxy)phenyl]sulfonyl}-2-(trifluoromethyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-7-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1034152-93-6 SDS

1034152-93-6Relevant articles and documents

Discovery of MK-7725, a potent, selective bombesin receptor subtype-3 agonist for the treatment of obesity

Chobanian, Harry R.,Guo, Yan,Liu, Ping,Chioda, Marc,Lanza, Thomas J.,Chang, Linda,Kelly, Theresa M.,Kan, Yanqing,Palyha, Oksana,Guan, Xiao-Ming,Marsh, Donald J.,Metzger, Joseph M.,Gorski, Judith N.,Raustad, Kate,Wang, Sheng-Ping,Strack, Alison M.,Miller, Randy,Pang, Jianmei,Madeira, Maria,Lyons, Kathy,Dragovic, Jasminka,Reitman, Marc L.,Nargund, Ravi P.,Lin, Linus S.

supporting information; experimental part, p. 252 - 256 (2012/07/13)

Extensive structure-activity relationship studies of a series derived from atropisomer 1, a previously described chiral benzodiazepine sulfonamide series, led to a potent, brain penetrant and selective compound with excellent preclinical pharmacokinetic a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1034152-93-6